MedPath

A study to determine the efficacy of amritadya guggulu and haritaki churna in medo roga

Phase 2
Conditions
Health Condition 1: E782- Mixed hyperlipidemia
Registration Number
CTRI/2023/11/059698
Lead Sponsor
Prof Anjana Mishra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who present with signs and symptoms of medoroga

Patients having serum cholesterol 200 to 300mg/dl, s. Triglycerides 150 to 350 mg/dl, S. LDL 100 to 200 mg/dl, S. VLDL 30 TO 100 mg/dl and S. HDL 20 to 40 mg/dl

Exclusion Criteria

Patients having past history of Myocardial infarction, unstable angina, congestive cardiac failure and cerebro vascular accident.

Patients having past illness like carcinoma, renal and liver disorders

Pregnant females and lactating mother

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath